PROCEDURE: Twelve regular users of marijuana underwent two positron emission tomography (PET) scans using [18F] Fluorodeoxyglucose (FDG), one while subject to the effects of 17 mg THC, the other without THC. In both sessions, a virtual reality maze task was performed during the FDG uptake period. RESULTS: When subject to the effects of 17 mg THC, regular marijuana smokers hit the walls more often on the virtual maze task than without THC. Compared to results without THC, 17 mg THC increased brain metabolism during task performance in areas that are associated with motor coordination and attention in the middle and medial frontal cortices and anterior cingulate, and reduced metabolism in areas that are related to visual integration of motion in the occipital lobes. CONCLUSION: These findings suggest that in regular marijuana users, the immediate effects of marijuana may impact on cognitive-motor skills and brain mechanisms that modulate coordinated movement and driving.
PROCEDURE: Twelve regular users of marijuana underwent two positron emission tomography (PET) scans using [18F] Fluorodeoxyglucose (FDG), one while subject to the effects of 17 mg THC, the other without THC. In both sessions, a virtual reality maze task was performed during the FDG uptake period. RESULTS: When subject to the effects of 17 mg THC, regular marijuana smokers hit the walls more often on the virtual maze task than without THC. Compared to results without THC, 17 mg THC increased brain metabolism during task performance in areas that are associated with motor coordination and attention in the middle and medial frontal cortices and anterior cingulate, and reduced metabolism in areas that are related to visual integration of motion in the occipital lobes. CONCLUSION: These findings suggest that in regular marijuana users, the immediate effects of marijuana may impact on cognitive-motor skills and brain mechanisms that modulate coordinated movement and driving.
Authors: Scott D Lane; Don R Cherek; Oleg V Tcheremissine; Lori M Lieving; Cythia J Pietras Journal: Neuropsychopharmacology Date: 2005-04 Impact factor: 7.853
Authors: Jennifer T Sneider; Harrison G Pope; Marisa M Silveri; Norah S Simpson; Staci A Gruber; Deborah A Yurgelun-Todd Journal: Exp Clin Psychopharmacol Date: 2006-11 Impact factor: 3.157
Authors: Daniel S O'Leary; Robert I Block; Julie A Koeppel; Michael Flaum; Susan K Schultz; Nancy C Andreasen; Laura Boles Ponto; G Leonard Watkins; Richard R Hurtig; Richard D Hichwa Journal: Neuropsychopharmacology Date: 2002-06 Impact factor: 7.853
Authors: Ian H Harding; Nadia Solowij; Ben J Harrison; Michael Takagi; Valentina Lorenzetti; Dan I Lubman; Marc L Seal; Christos Pantelis; Murat Yücel Journal: Neuropsychopharmacology Date: 2012-04-25 Impact factor: 7.853
Authors: Melissa P Lopez-Larson; Jadwiga Rogowska; Piotr Bogorodzki; Charles Elliott Bueler; Erin C McGlade; Deborah A Yurgelun-Todd Journal: Psychiatry Res Date: 2012-07-24 Impact factor: 3.222
Authors: Ersilia M DeFilippis; Navkaranbir S Bajaj; Amitoj Singh; Rhynn Malloy; Michael M Givertz; Ron Blankstein; Deepak L Bhatt; Muthiah Vaduganathan Journal: J Am Coll Cardiol Date: 2020-01-28 Impact factor: 24.094
Authors: Albert Batalla; Sagnik Bhattacharyya; Murat Yücel; Paolo Fusar-Poli; Jose Alexandre Crippa; Santiago Nogué; Marta Torrens; Jesús Pujol; Magí Farré; Rocio Martin-Santos Journal: PLoS One Date: 2013-02-04 Impact factor: 3.240